|Articles|January 1, 2003

January 2003
Volume 9
Issue 1

Effects of Ambulatory-Care Pharmacist Consultation on Mortality and Hospitalization

Author(s)Yong Yuan, PhD, Joel W. Hay, PhD, Jeffrey S. McCombs, PhD

Download PDF: Effects of Ambulatory-Care Pharmacist Consultation on Mortality and Hospitalization

Articles in this issue

over 23 years ago

Article

Identifying Individuals at Risk for the Development of Type 2 Diabetes Mellitus

over 23 years ago

Article

Impact of an Antidepressant Management Program on Medication Adherence

over 23 years ago

Article

Efficacy of Inhaled Corticosteroids Administered Once Daily for Asthma

over 23 years ago

Article

Medicaid Managed Care: Are Academic Medical Centers Penalized by Attracting Patients With High-Cost Conditions?

over 23 years ago

Article

The Cost Effectiveness of 5 Interventions to Increase Mammography Adherence in a Managed Care Population

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe

Related Content

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

ByHeather L. Taylor, MPH, LDH,Ann M. Holmes, PhD,Nir Menachemi, PhD, MPH,Justin Blackburn, PhD

July 10th 2026

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

ByChristopher Scannell, MD, PhD,John A. Romley, PhD,Rebecca Myerson, PhD,Dana Goldman, PhD,Dima Mazen Qato, PharmD, PhD, MPH

July 9th 2026

Upper Payment Limit Implementation Risks for Patients, Pharmacies, and Providers

ByJulie A. Patterson, PharmD, PhD,Roswell A. Cole, PharmD, MPH,Jonathan D. Campbell, PhD, MS,John Michael O’Brien, PharmD, MPH

July 9th 2026

The New Oncology Blueprint: Integrating Clinical Intelligence for Sustainable Value

ByVivian T. E. Tar, PharmD, MBA

July 8th 2026

Readability of Hospital Patient Financial Policy Documents

BySamantha Randall, BA,Sumedha Raghu, MS,Ella Cho,Nina Linh Nguyen, MHA,Erin Trish, PhD,Erin L. Duffy, PhD, MPH

July 7th 2026

Effects of Ambulatory-Care Pharmacist Consultation on Mortality and Hospitalization

Articles in this issue

Related Content

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

Upper Payment Limit Implementation Risks for Patients, Pharmacies, and Providers

The New Oncology Blueprint: Integrating Clinical Intelligence for Sustainable Value

Readability of Hospital Patient Financial Policy Documents

Trending on AJMC

Michigan Cyclospora Outbreak Surpasses 1500 Cases as Investigation Continues

FDA Approves Isatuximab On-Body Injector, Raising Anti-CD38 Competition in Myeloma

Upcoming 2026 FDA Decisions Could Expand Treatment Options Across Oncology and Hepatitis B

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

FDA Expands Pembrolizumab-Enfortumab for Muscle-Invasive Bladder Cancer

Access, Affordability, & Accountability: A New Era in Oncology Reimbursement

Effects of Ambulatory-Care Pharmacist Consultation on Mortality and Hospitalization

Articles in this issue

Related Content

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

Upper Payment Limit Implementation Risks for Patients, Pharmacies, and Providers

The New Oncology Blueprint: Integrating Clinical Intelligence for Sustainable Value

Readability of Hospital Patient Financial Policy Documents

Trending on AJMC

Michigan Cyclospora Outbreak Surpasses 1500 Cases as Investigation Continues

FDA Approves Isatuximab On-Body Injector, Raising Anti-CD38 Competition in Myeloma

Upcoming 2026 FDA Decisions Could Expand Treatment Options Across Oncology and Hepatitis B

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

FDA Expands Pembrolizumab-Enfortumab for Muscle-Invasive Bladder Cancer